As of 2024-12-15, the Relative Valuation of Olema Pharmaceuticals Inc (OLMA) is (47.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.75 USD, the upside of Olema Pharmaceuticals Inc based on Relative Valuation is -810.5%.
The range of the Relative Valuation is (44.36) - (41.15) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 31.0x | 25.8x |
| Forward P/E multiples | 18.7x - 19.2x | 19.0x |
| Fair Price | (44.36) - (41.15) | (47.96) |
| Upside | -757.2% - -709.6% | -810.5% |
| Date | P/E |
| 2024-11-22 | -4.10 |
| 2024-11-21 | -3.68 |
| 2024-11-20 | -3.87 |
| 2024-11-19 | -4.07 |
| 2024-11-18 | -4.03 |
| 2024-11-15 | -4.28 |
| 2024-11-14 | -4.72 |
| 2024-11-13 | -5.36 |
| 2024-11-12 | -5.39 |
| 2024-11-11 | -5.94 |
| 2024-11-08 | -5.79 |
| 2024-11-07 | -5.79 |
| 2024-11-06 | -5.85 |
| 2024-11-05 | -5.63 |
| 2024-11-04 | -5.54 |
| 2024-11-01 | -5.43 |
| 2024-10-31 | -5.39 |
| 2024-10-30 | -5.43 |
| 2024-10-29 | -5.54 |
| 2024-10-28 | -5.52 |
| 2024-10-25 | -5.39 |
| 2024-10-24 | -5.47 |
| 2024-10-23 | -5.56 |
| 2024-10-22 | -5.82 |
| 2024-10-21 | -5.64 |
| 2024-10-18 | -5.81 |
| 2024-10-17 | -5.75 |
| 2024-10-16 | -5.74 |
| 2024-10-15 | -5.44 |
| 2024-10-14 | -5.48 |
| 2024-10-11 | -5.48 |
| 2024-10-10 | -5.21 |
| 2024-10-09 | -5.26 |
| 2024-10-08 | -5.32 |
| 2024-10-07 | -5.29 |
| 2024-10-04 | -5.42 |
| 2024-10-03 | -5.40 |
| 2024-10-02 | -5.63 |
| 2024-10-01 | -5.74 |
| 2024-09-30 | -5.58 |
| 2024-09-27 | -5.69 |
| 2024-09-26 | -5.71 |
| 2024-09-25 | -5.79 |
| 2024-09-24 | -5.89 |
| 2024-09-23 | -6.06 |
| 2024-09-20 | -6.37 |
| 2024-09-19 | -6.35 |
| 2024-09-18 | -5.98 |
| 2024-09-17 | -5.73 |
| 2024-09-16 | -5.71 |